Call 408.493.1800 | Fax 408.493.1801 | Toll Free 800.891.9699 (US Only) | Email: [email protected]

Anti-CD3 epsilon (Muromonab), Mouse IgG2a, kappa Antibody

Protein A purified recombinant monoclonal antibody to detect CD3 epsilon subunit in humans
Catalog #: A2008

Product Details

Size 200 μg
Antibody Target CD3 epsilon
Alternate Name T-cell surface glycoprotein CD3 epsilon chain; T-cell surface antigen T3/Leu-4 epsilon chain; CD3e; OKT3
Host Recombinant
Antibody Type Monoclonal
Isotype Mouse IgG2a, kappa
Immunogen Human peripheral E+ cells
Accession # P07766
Gene ID 916
Appearance Colorless liquid
Concentration 1 mg/ml
Formulation In PBS with 0.02% Proclin 300
Purification Protein A affinity purified
Species Reactivity Human
Application Immunofluorescence (IF), Flow Cytometry
Application & Usage FC, IF
Handling The antibody solution should be gently mixed before use.
Storage Conditions -20ºC
Shipping Conditions Gel Pack
USAGE For Research Use Only! Not For Use in Humans.


Recombinant monoclonal antibody to CD3 epsilon. Manufactured using Recombinant Platform with variable regions (i.e. specificity) from the hybridoma OKT-3 (Muromonab). Epitope on the epsilon-subunit within the human CD3 complex. This chimeric human antibody was made using the variable domain sequences of the original Mouse IgG2a format, for improved compatibility with existing reagents, assays and techniques

Why buy BioVision Products?
Global Presence
Technical Support
BioVision aims to provide our customers innovative tools for accelerating drug discovery and biological research. BioVision offers >8,000 products including the most comprehensive array of assay kits for key targets in Metabolic pathways.
BioVision is committed to providing the highest quality products at a competitive price.
We have a broad network of global distributors who are ready to address your research needs and ensure fast delivery.
Our highly trained Technical Support team provides comprehensive product support and is dedicated to resolving your issues quickly and efficiently.